Fungi Lurking in Your Nose Could Be Worsening Your Allergies
A new study reveals that individuals with allergic rhinitis and asthma have distinct nasal fungal profiles, hinting at potential new treatment targets and the need for further investigation. Allergic ...
emjreviews.com22h
NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
Medindia2h
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Hosted on MSN7d
Understanding the Causes and Symptoms of Allergic Rhinitis
Allergic rhinitis is a very common condition often termed as hay fever, which affects millions of people globally. This ...
The Pharma Letter8d
First-in-class treatment approved by NICE for allergic rhinitis
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
'Life-changing' tablet for dust mite allergies
Thousands of people with a severe dust mite allergy could benefit from a "life changing" new daily treatment. The National ...
Everything you need to know about dust mite allergies as 'life changing' pill offered on NHS
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...
'Life-changing' treatment could help thousands of people with severe dust mite allergy
The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...
Medindia2h
Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment
CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...
ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ...
Keymed Biosciences Inc.: Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
National Institute for Health and Care Excellence8d
Thousands of people with a severe dust mite allergy are set to benefit from life-changing treatment
The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...